Fact sheets
These information sheets explain what the clinical care standard means for consumer, clinicians and healthcare services.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains
What do clinicians need to know?
The standard contains eight quality statements to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.
What are psychotropic medicines?
Psychotropic medicines are used mainly to treat mental health conditions like schizophrenia, anxiety, depression, and bipolar disorder. Some psychotropic medicines can also be used for health conditions such as pain or sleeping problems.
This issue includes items on maternal morbidity, the Patient-Reported Indicator Surveys, opioid stewardship, airway management, patient experiences and patient belongings, low back pain, COVID-19, and more.
Also covered are the latest issues of The Joint Commission on Quality and Patient Safety and Australian Health Review along with early online papers from BMJ Quality & Safety and the latest from the UK’s NICE and NIHR and the USA’s AHRQ.
On the Radar Issue 635 is now available.
This Requirement sets out the standards for using Human Papillomavirus nucleic acid testing as the primary screening method for cervical cancer screening.
This document will be replacing three previous Tier 4 NPAAC documents, namely:
On the Radar Issue 634 is now available.
This issue includes items on aged care, communication, satisfaction, hospital accreditation, diagnostic error, COVID-19, and more.
Also covered are the latest issues of BMJ Quality & Safety, Milbank Quarterly, and BMJ Leader along with early online papers from BMJ Quality & Safety and International Journal for Quality in Health Care and the latest from the NSW Agency for Clinical Innovation (ACI), the UK’s NICE and the USA’s AHRQ.